HCA
FATE icon

Harbor Capital Advisors’s Fate Therapeutics FATE Stock Holding History

Harbor Capital Advisors’s Portfolio FATE Stock Details FATE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-19,375
Closed -$142K – 740
2024
Q1 		$142K Buy
19,375
+3,844
+25% +$23.8K 0.02% 681
2023
Q4 		$58.1K Buy
15,531
+725
+5% +$1.71K 0.01% 430
2023
Q3 		$31.4K Buy
14,806
+2,678
+22% +$8.87K 0.01% 442
2023
Q2 		$57.7K Buy
12,128
+1,132
+10% +$6.25K 0.01% 481
2023
Q1 		$62.7K Buy
10,996
+82
+0.8% +$495 0.02% 242
2022
Q4 		$110K Sell
10,914
-232
-2% -$4.36K 0.11% 84
2022
Q3 		$250K Sell
11,146
-306
-3% -$8.84K 0.23% 79
2022
Q2 		$284K Sell
11,452
-1,256
-10% -$34.7K 0.22% 77
2022
Q1 		$493K Sell
12,708
-1,869
-13% -$72.4K 0.23% 79
2021
Q4 		$853K Buy
+14,577
New +$826K 0.31% 79

Other funds holding FATE

RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $4.85B AUM 144% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $141B AUM 30.34% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $127B AUM 43.98% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return